Skip to main content

Effect of hemolysis on the concentration of insulin in serum determined by RIA and IRMA.

Chevenne D, Letailleur A, Trivin F, Porquet D

Publication: Clin Chem (1998) • Vol 44 • Page 354-6PMID: 9474041View on PubMed

Purpose

The purpose of this paper was to determine the effects of hemolysis, storage temperature, and insulin-degrading enzyme (IDE) inhibitors on insulin in serum measured by radioimmunoassay (RIA) and immunoradiometric assay (IRMA).

Conclusion

Insulin levels, as measured by IRMA and RIA, decreased with increasing levels of hemolysate added to the serum and with increasing storage temperature. p-chloromercuriphenylsulfonic acid (pcMPS) or diamide partially attenuated the effects of added hemolysate on serum insulin levels. Slightly greater decreases in insulin were measured by IRMA than by RIA.

Studies (1)

Purpose

The purpose of this study was to determine the effects of increasing levels of hemolysis, storage temperature, and the addition of IDE inhibitors on levels of insulin in serum measured by RIA and IRMA. Red blood cells lysed by freezing were added to serum to achieve the desired concentration of hemoglobin. Details on the collection of blood for this study were not discussed.

Summary of Findings

Insulin levels, as measured by IRMA and RIA, decreased with increasing levels of hemolysate added to the serum (as much as 55-67% at 20 degrees C). Larger decreases were measured at higher storage temperatures such that after 1 h at 37 degrees C, serum with 6 g/L hemoglobin added only had 2.5% as much insulin as the original serum. The addition of pcMPS or diamide limited the hemolysate-induced decrease to <20%, but insulin levels were still significantly lower than in serum to which no hemolysate was added. The authors report that the addition of EDTA or 1.10-phenanthroline had no effect on insulin levels. Slightly greater decreases in insulin were measured by IRMA than by RIA.
  • Biospecimens

    FluidSerum
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Not specified
  • Platforms

    ProteinImmunoradiometric assay
    ProteinRadioimmunoassay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBiospecimen components
    0.4 mmol/L pcMPS
    0.5 g/ L hemoglobin
    1 g/ L hemoglobin
    1.10-phenanthroline
    2 g/ L hemoglobin
    4 g/ L hemoglobin
    5 mmol/L EDTA
    5 mmol/L diamide
    6 g/ L hemoglobin
    Biospecimen Aliquots and ComponentsHemolysis
    Absent
    Freeze/thaw-induced
    Hemolysate added
    StorageStorage duration
    0 h
    1 h
    StorageStorage temperature
    20 degrees C
    37 degrees C
    4 degrees C
    Radioimmunoassay SpecificTechnology platform
    IRMA